MediciNova arranges $6 million at-the-market offering of common stock

Macquarie is the agent; proceeds slated for general corporate purposes

By Devika Patel

Knoxville, Tenn., April 18 - MediciNova, Inc. negotiated a $6 million at-the-market offering of common stock with agent Macquarie Capital (USA) Inc., according to a prospectus supplement filed Thursday with the Securities and Exchange Commission.

Macquarie will be paid an 8% commission.

Proceeds will be used for research and development efforts and general corporate purposes, including working capital.

MediciNova is a San Diego-based development-stage biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.